FDA Should Release Existing Supply Of Primatene Mist OTC Asthma Inhaler, Rep. Says
This article was originally published in The Pink Sheet Daily
Lawmakers seek to restore the availability of Primatene Mist while the absence of an alternative OTC asthma remedy persists.
You may also be interested in...
The Health Choices Coalition sent letters urging House and Senate members to support legislation that would strike the health care reform law requirement that consumers obtain a prescription in order to purchase OTCs with a pre-tax savings account.